GlyGenix Therapeutics' Seed VC Round

GlyGenix Therapeutics raised a round of funding on March 17, 2014. Investors include Connecticut Innovations.

GlyGenix Therapeutics (GTI) is focused on treating and curing Glycogen Storage Diseases (GSDs). The company's primary focus is to cure GSD type 1a, which is caused by an inherited gene mutation result…

Articles about GlyGenix Therapeutics' Seed VC Round: